NovaBay Pharmaceuticals
16 hedge funds and large institutions have $101K invested in NovaBay Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TSS
Two Sigma Securities
New York
|
+$18.9K |
2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$9.7K |
3 |
VF
Virtu Financial
New York
|
+$4.99K |
4 |
CWM
C2C Wealth Management
Scottsdale,
Arizona
|
+$4.78K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.02K |
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
-$14.5K |
2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$6.89K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$18 |